The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Clinical Effectiveness of Beta-Blockers in Heart Failure
Open accessAbstract
Objectives We sought to examine associations between initiation of beta-blocker therapy and outcomes among elderly patients hospitalized for heart failure. Background Beta-blockers are guideline-recommended therapy for heart failure, but their clinical effectiveness is not well-understood, especially in elderly patients. Methods We merged Medicare claims data with OPTIMIZE-HF records to examine long-term outcomes of eligible patients newly initiated on beta-blocker therapy. We used inverse probability-weighted Cox proportional hazards models to determine the relationships between treatment and mortality, rehospitalization, and a combined mortality–rehospitalization endpoint. Results Observed 1-year mortality was 33%, and all-cause rehospitalization was 64%. Among 7154 patients hospitalized with heart failure and eligible for beta-blockers, 3421 (49%) were newly initiated on beta-blocker therapy. Among patients with left ventricular systolic dysfunction (LVSD; n = 3001), beta-blockers were associated with adjusted hazard ratios of 0.77 (95% confidence interval [CI], 0.68–0.87) for mortality, 0.89 (95% CI, 0.80–0.99) for rehospitalization, and 0.87 (95% CI, 0.79–0.96) for mortality–rehospitalization. Among patients with preserved systolic function (n = 4153), beta-blockers were associated with adjusted hazard ratios of 0.94 (95% CI, 0.84–1.07) for mortality, 0.98 (95% CI, 0.90–1.06) for rehospitalization, and 0.98 (95% CI, 0.91–1.06) for mortality-rehospitalization. Conclusions In elderly patients hospitalized with heart failure and LVSD, incident beta-blocker use was clinically effective and independently associated with lower risks of death and rehospitalization. Patients with preserved systolic function had poor outcomes, and beta-blockers did not significantly influence the mortality and rehospitalization risks for these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
(1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,929
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
Writing Group Members, Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.187998 · Cited by 3,711
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations
Boudoulas, K. D., Borer, J. S., & Boudoulas, H. (2015) · Cardiology · doi:10.1159/000435947 · Cited by 1,938
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661
Flather, M. D., Shibata, M. C., Coats, A. J. S., Van Veldhuisen, D. J., Parkhomenko, A., Borbola, J., Cohen-Solal, A., Dumitrascu, D., Ferrari, R., Lechat, P., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi115 · Cited by 1,655
Gheorghiade, M., Abraham, W. T., Albert, N. M., Greenberg, B. H., O’Connor, C. M., She, L., Stough, W. G., Yancy, C. W., Young, J. B., Fonarow, G. C., et al. (2006) · JAMA · doi:10.1001/jama.296.18.2217 · Cited by 975
Self-citationDigoxin in Heart Failure with a Reduced Ejection Fraction: A Risk Factor or a Risk Marker?
Konstantinou, D. M., Karvounis, H., & Giannakoulas, G. (2016) · Cardiology · doi:10.1159/000444078 · Cited by 870
Readmission After Hospitalization for Congestive Heart Failure Among Medicare Beneficiaries
Krumholz, H. M. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.1.99 · Cited by 821
Adjusted survival curves with inverse probability weights
Cole, S. R., & Hernán, M. A. (2004) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2003.10.004 · Cited by 814
Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials
Heiat, A., Gross, C. P., & Krumholz, H. M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1682 · Cited by 723 · cited 1×
“Patients enrolled in andomized clinical trials tend to be relatively young, have elatively few comorbid conditions, and are not representaive of the general heart failure population encountered in linical practice (7).”
Fonarow, G. C., Abraham, W. T., Albert, N. M., Stough, W. G., Gheorghiade, M., Greenberg, B. H., O’Connor, C. M., Pieper, K., Sun, J. L., Yancy, C., et al. (2007) · JAMA · doi:10.1001/jama.297.1.61 · Cited by 463
Self-citationCardiomyopathy, U. (2007) · Digest of the World Core Medical Journals(Cardiology) · Cited by 416
Ezekowitz, J., McAlister, F. A., Humphries, K. H., Norris, C. M., Tonelli, M., Ghali, W. A., & Knudtson, M. L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.072 · Cited by 377
Principles for modeling propensity scores in medical research: a systematic literature review
Weitzen, S., Lapane, K. L., Toledano, A. Y., Hume, A. L., & Mor, V. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.969 · Cited by 344
Fonarow, G. C., Abraham, W. T., Albert, N. M., Gattis, W. A., Gheorghiade, M., Greenberg, B., O'Connor, C. M., Yancy, C. W., & Young, J. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.004 · Cited by 342
Self-citationDeath in Heart Failure: A Community Perspective
Henkel, D. M., Redfield, M. M., Weston, S. A., Gerber, Y., & Roger, V. L. (2008) · Circulation: Heart Failure · doi:10.1161/circheartfailure.107.743146 · Cited by 286
Fonarow, G. C. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.14.1493 · Cited by 267
Self-citationRisk-Treatment Mismatch in the Pharmacotherapy of Heart Failure
Lee, D. S. (2005) · JAMA · doi:10.1001/jama.294.10.1240 · Cited by 257
Fonarow, G. C., Abraham, W. T., Albert, N. M., Stough, W. G., Gheorghiade, M., Greenberg, B., O’Connor, C. M., Sun, J. L., Yancy, C. W., & Young, J. B. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.10.008 · Cited by 118
Self-citationTrends in heart failure outcomes and pharmacotherapy: 1992 to 2000
Lee, D. S., Mamdani, M., Austin, P. C., Gong, Y., Liu, P. P., Rouleau, J. L., & Tu, J. V. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.11.025 · Cited by 99
Curtis, L. H., Greiner, M. A., Hammill, B. G., DiMartino, L., Shea, A. M., Hernandez, A. F., & Fonarow, G. C. (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.822692 · Cited by 96
Self-citationFonarow, G. C., Abraham, W. T., Albert, N. M., Stough, W. G., Gheorghiade, M., Greenberg, B., O’Connor, C. M., Sun, J. L., Yancy, C. W., & Young, J. B. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.06.727 · Cited by 73
Self-citationUtilizing Propensity Scores to Estimate Causal Treatment Effects with Censored Time-Lagged Data
Anstrom, K. J., & Tsiatis, A. A. (2001) · Biometrics · doi:10.1111/j.0006-341x.2001.01207.x · Cited by 60
Go, A. S., Yang, J., Gurwitz, J. H., Hsu, J., Lane, K., & Platt, R. G. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.084 · Cited by 41
Patel, P., White, D. L., & Deswal, A. M. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.01.037 · Cited by 31
Cited by
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Self-citation2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862
Self-citationPulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
Lam, C. S. P., Roger, V. L., Rodeheffer, R. J., Borlaug, B. A., Enders, F. T., & Redfield, M. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.051 · Cited by 1,341
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
Borlaug, B. A., & Paulus, W. J. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq426 · Cited by 1,093
Kittleson, M. M., Panjrath, G. S., Amancherla, K., Davis, L. L., Deswal, A., Dixon, D. L., Januzzi, J. L., & Yancy, C. W. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.03.393 · Cited by 554
Metadata
- Authors
- Hernandez, A. F., Hammill, B. G., O'Connor, C. M., Schulman, K. A., Curtis, L. H., & Fonarow, G. C.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 53
- Issue
- 2
- Pages
- 184-192
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W136210392
- Cited by
- 333
- References
- 31
- FWCI
- 14.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.